Global DNA Repair Drugs Market
Global DNA Repair Drugs Market Poised for Remarkable Growth: Key Insights and Projections for 2024-2034
30 janv. 2024 03h33 HE | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Global DNA Repair Drugs Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. Emerging Trends and...
Global DNA Repair Drugs Market
DNA Repair Drugs Market Projected for Accelerated Growth, New Research Highlights Industry Trends and Opportunities
25 janv. 2024 20h23 HE | Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "DNA Repair Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.As the fight against cancer continues, the...
Global Market for microRNA (miRNA)
microRNA (miRNA) Global Market is Projected to Reach $840.8 Billion by 2030: Increasing Demand for Liquid Biopsies to Drive Growth
30 juin 2023 05h03 HE | Research and Markets
Dublin, June 30, 2023 (GLOBE NEWSWIRE) -- The "microRNA (miRNA): Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for microRNA (miRNA)...
Full Latin without Latin logo.png
CLINUVEL Drug Significantly Reduces Critical UV Skin Damage in Fair-Skinned Individuals
01 févr. 2023 19h14 HE | Clinuvel Pharmaceuticals Limited
MELBOURNE, Australia, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Results released today from a clinical study have shown that the drug afamelanotide can reduce critical skin damage caused by ultraviolet (UV)...
Full Latin without Latin logo.png
CLINUVEL Trial Results Show Drug Reduces DNA Damage
15 janv. 2023 18h23 HE | Clinuvel Pharmaceuticals Limited
MELBOURNE, Australia, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Results from a clinical trial in a genetic DNA repair disorder show that a new drug – afamelanotide – may be able to reduce the development of...
Global DNA Repair Drugs Market
Worldwide DNA Repair Drugs Industry to 2026 - by Technology Type, Application and Region
25 févr. 2022 09h23 HE | Research and Markets
Dublin, Feb. 25, 2022 (GLOBE NEWSWIRE) -- The "DNA Repair Drugs: Global Markets" report has been added to ResearchAndMarkets.com's offering. This report provides an in-depth examination of the...
22157.jpg
Global microRNA (miRNA) Market Research Report 2021: Increasing Incidence of Infectious Diseases and Chronic Conditions to Help miRNA Market Gallop Ahead
19 janv. 2022 06h28 HE | Research and Markets
Dublin, Jan. 19, 2022 (GLOBE NEWSWIRE) -- The "microRNA (miRNA) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global microRNA (miRNA) Market...
22157.jpg
Global Targeted Therapeutics Market Research Report 2021: Market will Surpass $100+ Billion in 2021 - Forecast to 2026
15 déc. 2021 09h03 HE | Research and Markets
Dublin, Dec. 15, 2021 (GLOBE NEWSWIRE) -- The "Global Targeted Therapeutics Market 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for targeted...
22157.jpg
Global DNA Damage Response Targeting Therapeutics Market Report 2021: Current Landscape and the Likely Adoption of DNA Damage Response Targeting Therapeutics in Healthcare Over the Next Decade
06 oct. 2021 06h23 HE | Research and Markets
Dublin, Oct. 06, 2021 (GLOBE NEWSWIRE) -- The "DNA Damage Response Targeting Therapeutics Market by Target Disease Indication, Therapeutic Area, Target Molecule, Type of Molecule, Route of...
Full Latin without Latin logo.png
CLINUVEL expands DNA Repair Program
23 mars 2021 20h10 HE | Clinuvel Pharmaceuticals Limited
SCENESSE® (afamelanotide 16mg) to be evaluated in xeroderma pigmentosum variant (XP-V) MELBOURNE, Australia, March 24, 2021 (GLOBE NEWSWIRE) -- CLINUVEL has expanded its clinical program to...